Previous Close | 119.70 |
Open | 115.42 |
Bid | 115.74 x 0 |
Ask | 116.28 x 0 |
Day's Range | 114.86 - 116.96 |
52 Week Range | 59.44 - 132.06 |
Volume | |
Avg. Volume | 813 |
Market Cap | 44.131B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.